113 related articles for article (PubMed ID: 9875393)
1. Broad-spectrum antiviral activity and mechanism of antiviral action of the fluoroquinolone derivative K-12.
Witvrouw M; Daelemans D; Pannecouque C; Neyts J; Andrei G; Snoeck R; Vandamme AM; Balzarini J; Desmyter J; Baba M; De Clercq E
Antivir Chem Chemother; 1998 Sep; 9(5):403-11. PubMed ID: 9875393
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
Okamoto M; Okamoto T; Baba M
Antimicrob Agents Chemother; 1999 Mar; 43(3):492-7. PubMed ID: 10049256
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives.
Baba M; Okamoto M; Kawamura M; Makino M; Higashida T; Takashi T; Kimura Y; Ikeuchi T; Tetsuka T; Okamoto T
Mol Pharmacol; 1998 Jun; 53(6):1097-103. PubMed ID: 9614214
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the tax-dependent human T-lymphotropic virus type I replication in persistently infected cells by the fluoroquinolone derivative k-37.
Wang X; Miyake H; Okamoto M; Saito M; Fujisawa J; Tanaka Y; Izumo S; Baba M
Mol Pharmacol; 2002 Jun; 61(6):1359-65. PubMed ID: 12021397
[TBL] [Abstract][Full Text] [Related]
6. "Viologen" dendrimers as antiviral agents: the effect of charge number and distance.
Asaftei S; De Clercq E
J Med Chem; 2010 May; 53(9):3480-8. PubMed ID: 20377249
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
[TBL] [Abstract][Full Text] [Related]
8. Antiviral properties of quinolone-based drugs.
Richter S; Parolin C; Palumbo M; Palù G
Curr Drug Targets Infect Disord; 2004 Jun; 4(2):111-6. PubMed ID: 15180459
[TBL] [Abstract][Full Text] [Related]
9. 3-(5-Dimethylamino-1-naphthalenesulphonyl)-2-(3-pyridyl)thiazolidine (YHI-1) selectively inhibits human immunodeficiency virus type 1.
Premanathan M; Arakaki R; Ramanan S; Jinno S; Baba M; Yamashita S; Nakashima H
Antivir Chem Chemother; 1998 Sep; 9(5):423-30. PubMed ID: 9875395
[TBL] [Abstract][Full Text] [Related]
10. 5'-Nor carbocyclic 5'-deoxy-5'-(isobutylthio)adenosine and a 2',3'-dideoxy-2',3'-didehydro derivative.
Das SR; Schneller SW; Balzarini J; De Clercq E
Antivir Chem Chemother; 2001 Mar; 12(2):119-24. PubMed ID: 11527043
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
12. Polyanion inhibitors of human immunodeficiency virus and other viruses. 6. Micelle-like anti-HIV polyanionic compounds based on a carbohydrate core.
Leydet A; Jeantet-Segonds C; Bouchitté C; Moullet C; Boyer B; Roque JP; Witvrouw M; Este J; Snoeck R; Andrei G; De Clercq E
J Med Chem; 1997 Jan; 40(3):350-6. PubMed ID: 9022801
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antiviral and cytotoxic activity of 6-bromo-2,3-disubstituted-4(3H)-quinazolinones.
Dinakaran M; Selvam P; DeClercq E; Sridhar SK
Biol Pharm Bull; 2003 Sep; 26(9):1278-82. PubMed ID: 12951471
[TBL] [Abstract][Full Text] [Related]
14. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.
Stevens M; Balzarini J; Tabarrini O; Andrei G; Snoeck R; Cecchetti V; Fravolini A; De Clercq E; Pannecouque C
J Antimicrob Chemother; 2005 Nov; 56(5):847-55. PubMed ID: 16150861
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral evaluation of C5-substituted-(1,3-diyne)-2'-deoxyuridines.
Sari O; Roy V; Balzarini J; Snoeck R; Andrei G; Agrofoglio LA
Eur J Med Chem; 2012 Jul; 53():220-8. PubMed ID: 22578783
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101.
Wang X; Yamataka K; Okamoto M; Ikeda S; Baba M
Antivir Chem Chemother; 2007; 18(4):201-11. PubMed ID: 17907378
[TBL] [Abstract][Full Text] [Related]
17. Polyanion inhibitors of human immunodeficiency virus and other viruses. 5. Telomerized anionic surfactants derived from amino acids.
Leydet A; Barragan V; Boyer B; Montéro JL; Roque JP; Witvrouw M; Este J; Snoeck R; Andrei G; De Clercq E
J Med Chem; 1997 Jan; 40(3):342-9. PubMed ID: 9022800
[TBL] [Abstract][Full Text] [Related]
18. 5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity.
Hocková D; Holý A; Masojídková M; Andrei G; Snoeck R; De Clercq E; Balzarini J
J Med Chem; 2003 Nov; 46(23):5064-73. PubMed ID: 14584956
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
20. 6-Aminoquinolones as new potential anti-HIV agents.
Cecchetti V; Parolin C; Moro S; Pecere T; Filipponi E; Calistri A; Tabarrini O; Gatto B; Palumbo M; Fravolini A; Palu' G
J Med Chem; 2000 Oct; 43(20):3799-802. PubMed ID: 11020296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
